---
title: "CG Oncology, Inc. (CGON) Receives a Rating Update from a Top Analyst"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286649053.md"
description: "LifeSci Capital analyst Sam Slutsky has maintained a Buy rating on CG Oncology, Inc. (CGON) with a price target of $108.00. Slutsky, who focuses on the Healthcare sector, has an average return of 44.6% and a 52.24% success rate on recommended stocks. Additionally, Bank of America Securities also maintained a Buy rating with a price target of $83.00."
datetime: "2026-05-16T14:36:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286649053.md)
  - [en](https://longbridge.com/en/news/286649053.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286649053.md)
---

# CG Oncology, Inc. (CGON) Receives a Rating Update from a Top Analyst

LifeSci Capital analyst Sam Slutsky maintained a Buy rating on CG Oncology, Inc. today and set a price target of $108.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Slutsky covers the Healthcare sector, focusing on stocks such as Spyre Therapeutics, Palvella Therapeutics, and Enliven Therapeutics. According to TipRanks, Slutsky has an average return of 44.6% and a 52.24% success rate on recommended stocks.

In a report released on May 14, Bank of America Securities also maintained a Buy rating on the stock with a $83.00 price target.

### Related Stocks

- [CGON.US](https://longbridge.com/en/quote/CGON.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)

## Related News & Research

- [Bank of America Securities Reaffirms Their Buy Rating on Inhibikase Therapeutics (IKT)](https://longbridge.com/en/news/286542293.md)
- [Stifel Nicolaus Keeps Their Buy Rating on Nurix Therapeutics (NRIX)](https://longbridge.com/en/news/286587770.md)
- [Leerink Partners Sticks to Their Buy Rating for Ibio (IBIO)](https://longbridge.com/en/news/286588262.md)
- [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md)
- [CG Oncology, Inc. (CGON) Gets a Buy from Cantor Fitzgerald](https://longbridge.com/en/news/285942639.md)